Live Quote · NASDAQCMMBHealthcare· Biotechnology

Chemomab Therapeutics Ltd.

$1.19▲ 4.39%(+$0.05)
MKT CAP $9.58MLAST EARNINGS Nov 6, 2026
50%
Bullish
TickerSpark Score
55/100
▌ Mixed
80
Valuation
20
Profitability
60
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CMMB research report →

Analyst RatingBuy
4 Buy0 Hold0 Sell

Price Chart

-51.03% · this period
$2.83$1.92$1.00Nov 20May 26Nov 20
52-Week Range13% of range
Low
$0.92
Current
$1.19
High
$2.99